MedMira Inc. (MIR.V)
- Previous Close
0.0750 - Open
0.0750 - Bid 0.0750 x --
- Ask 0.0800 x --
- Day's Range
0.0750 - 0.0750 - 52 Week Range
0.0700 - 0.1400 - Volume
24,830 - Avg. Volume
43,993 - Market Cap (intraday)
52.63M - Beta (5Y Monthly) 11.04
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Jun 28, 2024 - Jul 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. In addition, the company offers VYRATM TriDemic antigen rapid test that distinguishes the three respiratory viruses, such as SARS-CoV-2, influenza, and respiratory syncytial virus that exhibit similar symptoms. It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
www.medmira.comRecent News: MIR.V
Performance Overview: MIR.V
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MIR.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MIR.V
Valuation Measures
Market Cap
52.63M
Enterprise Value
60.70M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
128.34
Price/Book (mrq)
--
Enterprise Value/Revenue
148.87
Enterprise Value/EBITDA
-36.36
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-33.37%
Return on Equity (ttm)
--
Revenue (ttm)
407.78k
Net Income Avi to Common (ttm)
-2.92M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
853.82k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.15M
Company Insights: MIR.V
MIR.V does not have Company Insights